|Bid||0.8500 x N/A|
|Ask||1.1500 x N/A|
|Day's Range||0.8500 - 0.8500|
|52 Week Range||0.6000 - 1.5000|
|Beta (5Y Monthly)||-0.59|
|PE Ratio (TTM)||21.25|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
Phoenix Canada Oil Company Limited (TSXV:PCO) ("Phoenix") and ZYUS Life Sciences Inc. ("ZYUS" or the "Company"), a private Canadian life sciences company, together announce that they have entered into a Definitive Agreement dated November 15, 2022 (the "Agreement"). The Agreement is the Definitive Agreement contemplated by the non-binding letter of intent Phoenix and ZYUS entered into on May 27, 2022 and announced by press release dated May 30, 2022.
Phoenix Canada Oil Company Limited (TSXV:PCO) ("Phoenix" or the "Company") is pleased to provide an update to the Company's previously announced non-binding letter of intent (the "LOI") dated May 27, 2022 with ZYUS Life Sciences Inc. ("ZYUS"), a private Canadian life sciences company.